Your search for dabigatran returned 2 results

The World Health Organization (WHO) has updated the WHO Model List of Essential Medicines for 2019.

The open label, randomized, multicenter, phase 2b/3 DIVERSITY trial evaluated the efficacy and safety of dabigatran compared with SOC (low molecular weight heparin or vitamin K antagonist) in 240 children.